UConn Health is the branch of the University of Connecticut that oversees clinical care, advanced biomedical research, and academic education in medicine. The main branch is located in Farmington, Connecticut, in the US.

There are 224 beds in University of Connecticut Health Center.

During the past decade, University of Connecticut Health Center conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 81 clinical trials were completed, i.e. on average, 84.4% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 37 clinical trials were completed. i.e. 77.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Connecticut Health Center" #1 sponsor was "UConn Health" with 120 trials, followed by "Children's Oncology Group" with 21 trials sponsored, "National Cancer Institute (NCI)" with 17 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 15 trials sponsored and "Bristol-Myers Squibb" with 15 trials sponsored. Other sponsors include 158 different institutions and companies that sponsored additional 105 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Connecticut Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 26 trials as a collaborator, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 16 trials as a collaborator, "University of Connecticut" with 10 trials as a collaborator and "UConn Health" with 9 trials as a collaborator. Other collaborators include 209 different institutions and companies that were collaborators in the rest 157 trials.

According to Clinical.Site data, the most researched conditions in "University of Connecticut Health Center" are "HIV Infections" (16 trials), "Breast Cancer" (13 trials), "Substance Abuse" (9 trials), "Alcoholism" (8 trials) and "Alcohol Dependence" (7 trials). Many other conditions were trialed in "University of Connecticut Health Center" in a lesser frequency.

Most popular intervention types in "University of Connecticut Health Center" are "Drug" (193 trials), "Behavioral" (75 trials), "Other" (68 trials), "Biological" (34 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "Laboratory Biomarker Analysis" (20 trials), "placebo" (13 trials), "Paclitaxel" (11 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "University of Connecticut Health Center" are 277 trials for "All" genders, 57 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "University of Connecticut Health Center". undefined are not yet recruiting, 40 are recruiting, 23 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 232 completed trials in University of Connecticut Health Center, 1 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in University of Connecticut Health Center, 24 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 100 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 28 trials, and there were also 90 trials that are defined as “Not Applicable".